MENS
Price
$2.02
Change
-$0.04 (-1.94%)
Updated
Aug 14 closing price
Capitalization
149.95M
Intraday BUY SELL Signals
TRAW
Price
$0.57
Change
-$0.03 (-5.00%)
Updated
Aug 14 closing price
Capitalization
8.7M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MENS vs TRAW

MENS vs TRAW Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MENS vs. TRAW commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MENS is a Hold and TRAW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2026
Stock price -- (MENS: $2.02 vs. TRAW: $0.57)
Brand notoriety: MENS and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MENS: 13% vs. TRAW: 14%
Market capitalization -- MENS: $149.95M vs. TRAW: $8.7M
MENS [@Biotechnology] is valued at $149.95M. TRAW’s [@Biotechnology] market capitalization is $8.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MENS’s FA Score shows that 1 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • MENS’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, TRAW is a better buy in the long-term than MENS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MENS’s TA Score shows that 3 TA indicator(s) are bullish while TRAW’s TA Score has 4 bullish TA indicator(s).

  • MENS’s TA Score: 3 bullish, 7 bearish.
  • TRAW’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than MENS.

Price Growth

MENS (@Biotechnology) experienced а -0.49% price change this week, while TRAW (@Biotechnology) price change was +7.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.

Reported Earning Dates

TRAW is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MENS($150M) has a higher market cap than TRAW($8.7M). MENS (-48.861) and TRAW (-49.469) have similar YTD gains .
MENSTRAWMENS / TRAW
Capitalization150M8.7M1,725%
EBITDAN/A-19.51M-
Gain YTD-48.861-49.46999%
P/E RatioN/A1.94-
RevenueN/A2.73M-
Total CashN/A3.13M-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MENSTRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MENS
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRM1.080.06
+5.88%
MEDIROM Healthcare Technologies
GEO31.220.85
+2.80%
GEO Group (The)
SMID28.210.46
+1.66%
Smith-Midland Corp
CHT42.580.30
+0.71%
CHUNGHWA TELECOM CO Ltd
IPX23.57-0.45
-1.87%
IperionX Limited

MENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MENS has been loosely correlated with VTGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MENS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MENS
1D Price
Change %
MENS100%
-1.94%
VTGN - MENS
58%
Loosely correlated
+0.49%
KYTX - MENS
34%
Loosely correlated
+1.11%
BNTC - MENS
28%
Poorly correlated
N/A
TRAW - MENS
25%
Poorly correlated
-4.83%
FDMT - MENS
21%
Poorly correlated
+4.64%
More